Iridium-192 curietherapy for T1 and T2 epidermoid carcinomas of the floor of mouth.

Abstract

From 1970 to 1986, 117 patients with T1 (47) or T2 (70) epidermoid carcinomas of the floor of the mouth (SCC) were treated by iridium-192 implantation (192 Ir). The dose was prescribed according to the Paris System and varied over those years. Follow-up information was available on 116 patients. There were 46 T1N0, 47 T2N0, and 23 T2N1-3. Neck management… (More)

Topics

Cite this paper

@article{Mazeron1990Iridium192CF, title={Iridium-192 curietherapy for T1 and T2 epidermoid carcinomas of the floor of mouth.}, author={J.-J. Mazeron and L{\'a}val Grimard and Matthieu Raynal and {\'E}lie Haddad and Pascal Piedbois and M. Mart{\'i}n and Gabriel E. Marinello and Ravi Nair and Jean-Paul Le Bourgeois and Bernard Pierquin}, journal={International journal of radiation oncology, biology, physics}, year={1990}, volume={18 6}, pages={1299-306} }